VPS39 抗体 (AA 263-490)
-
- 抗原 See all VPS39 抗体
- VPS39 (Vacuolar Protein Sorting 39 Homolog (VPS39))
-
抗原表位
- AA 263-490
-
适用
- 人
-
宿主
- 兔
-
克隆类型
- 多克隆
-
标记
- This VPS39 antibody is un-conjugated
-
应用范围
- Western Blotting (WB), ELISA, Immunohistochemistry (IHC), Immunofluorescence (IF)
- 交叉反应
- 人, 小鼠
- 纯化方法
- >95%, Protein G purified
- 免疫原
- Recombinant Human Vam6/Vps39-like protein (263-490AA)
- 亚型
- IgG
-
-
- 应用备注
- Recommended dilution: WB:1:500-1:5000, IHC:1:20-1:200, IF:1:50-1:200,
- 限制
- 仅限研究用
-
- 状态
- Liquid
- 缓冲液
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4 - 储存液
- ProClin
- 注意事项
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- 储存条件
- -20 °C,-80 °C
- 储存方法
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
- 抗原
- VPS39 (Vacuolar Protein Sorting 39 Homolog (VPS39))
- 别名
- VPS39 (VPS39 产品)
- 背景
-
Background: Regulator of TGF-beta/activin signaling, inhibiting SMAD3- and activating SMAD2-dependent transcription. Acts by interfering with SMAD3/SMAD4 complex formation, this would lead to inhibition of SMAD3-dependent transcription and relieve SMAD3 inhibition of SMAD2-dependent promoters, thus increasing SMAD2-dependent transcription. Does not affect TGF-beta-induced SMAD2 or SMAD3 phosphorylation, nor SMAD2/SMAD4 complex formation.
Aliases: A230065P22Rik antibody, AW743070 antibody, FLJ21681 antibody, FLJ46546 antibody, hVam6p antibody, KIAA0770 antibody, RP23-348L16.12 antibody, TLP antibody, TRAP1 like protein antibody, Vacuolar protein sorting 39 antibody, Vacuolar protein sorting 39 homolog antibody, VAM6 antibody, Vam6/Vps39 like antibody, Vam6/Vps39 like protein antibody, Vam6/Vps39-like protein antibody, VPS 39 antibody, Vps39 antibody, VPS39_HUMAN antibody
- UniProt
- Q96JC1
- 途径
- SARS-CoV-2 Protein Interactome
-